Fieldline 64 Sensor
ID: NIMH25001453Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide equipment and services for the development of a non-invasive magnetocardiography (MCoG) array, focusing on the Fieldline V3 Sensor. The project aims to enhance the measurement of human neurophysiology by supplying 64 sensors and related hardware, as well as research and design services, including the prototyping of a compound gradiometer. This initiative is critical for advancing the understanding of brain function through improved non-invasive observation techniques. Interested parties must submit their qualifications and capabilities by January 22, 2025, and can contact Joseph Kennedy at joseph.kennedy@nih.gov or Marlene Milgram at marlene.milgram@nih.gov for further information.

    Point(s) of Contact
    Files
    Title
    Posted
    The SAM.gov Sources Sought Notice seeks information on qualified small businesses capable of providing equipment and services related to the development of a non-invasive magnetocardiography (MCoG) array, specifically the Fieldline V3 Sensor. Intended to enhance the measurement of human neurophysiology, this project requires businesses to submit documentation proving their ability to supply 64 sensors and related hardware as well as research and design services, including the prototyping of a compound gradiometer. Key objectives involve demonstrating MCoG feasibility and developing optimized sensors. The government emphasizes small business participation, requesting details on business classification and capabilities. The notice clarifies it is not a solicitation for proposals but aims to assess the market for potential sources. Responses must be submitted by January 22, 2025, focusing on specific project requirements, company qualifications, and ownership type. All submissions must ensure confidentiality and must be formatted correctly to be considered. This document serves a research purpose to shape future acquisition strategies, potentially leading to contract awards for successful respondents.
    Lifecycle
    Title
    Type
    Fieldline 64 Sensor
    Currently viewing
    Sources Sought
    Similar Opportunities
    Maintenance service for Mass Spectrometers and components
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide maintenance services for Mass Spectrometers and associated components utilized by the National Institute on Aging (NIA). The procurement aims to ensure the proper functioning of critical instruments, including the Q Exactive HF and Orbitrap Eclipse Tribid, which are essential for ongoing research in discovery proteomics and aging studies. Interested vendors must submit a capability statement detailing their qualifications, including employee numbers and relevant experience, by January 17, 2025, at 5:00 PM EST, to Iris Merscher at iris.merscher@nih.gov. This notice is a Sources Sought announcement and does not constitute a solicitation for proposals.
    SOURCES SOUGHT: Mass Spectrometry Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Aging (NIA), is seeking qualified small business sources for the procurement of specialized Mass Spectrometry Reagents aimed at advancing research on Alzheimer’s Disease and related dementias. The objective is to establish a national resource of isogenic induced pluripotent stem cell (iPSC) lines to study genetic mutations associated with these diseases, thereby accelerating mechanistic discovery. This procurement is critical for enhancing the understanding of Alzheimer’s disease mechanisms and includes specific requirements for HPLC columns and related supplies, with the first delivery expected by July 7, 2025, and additional options extending to July 2027. Interested parties should submit their capability statements to Rashiid Cummins at Rashiid.Cummins@nih.gov by January 21, 2025, at 3:00 PM Eastern Time.
    Inverted Routine Microscope System and Prime Life Science sCMOS Camera
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking information on domestically manufactured Inverted Routine Microscope Systems and Prime Life Science sCMOS Cameras. This Sources Sought notice aims to gather details regarding the availability and capability of U.S. manufactured products that meet specific technical specifications, including advanced imaging capabilities and various illumination options. The procurement is crucial for supporting the NIH's oversight of foreign grant recipients and enhancing their administrative operations. Interested vendors must submit their capability statements by 11:59 AM Eastern Time on January 10, 2025, to the NIAID electronic Simplified Acquisition Submission System (eSASS), with all submissions being treated confidentially. For further inquiries, vendors can contact Rubyanne Matthews at rubyanne.matthews@nih.gov.
    NUcleic acid Linked Immuno-Sandwich Assay Reagents
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of NUcleic acid Linked Immuno-Sandwich Assay Reagents, aimed at enhancing biomarker discovery for neurodegenerative disease research at the Center for Alzheimer’s Disease and Related Dementias (CARD). The acquisition includes the Alamar NULISAseq Inflammation Panel, with a requirement for 30 units that must demonstrate high sensitivity in analyzing over 250 proteins from minimal sample volumes, ensuring compatibility with the ARGO proteomics platform. This procurement is critical for advancing research capabilities in the detection of biomarkers related to Alzheimer’s Disease and Related Dementias (ADRD). Interested vendors must submit their quotations by January 22, 2025, at 12:00 PM Eastern Time, to Andrea Clay at amcgee@nida.nih.gov, and must comply with all specified federal regulations and provisions outlined in the solicitation.
    Cambridge Isotope L-Glutamine
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide L-Glutamine enriched with stable isotope 13C for neuroscience research. The procurement aims to secure domestically manufactured chemicals that are essential for enhancing carbon-13 MR spectroscopy signals, which are critical for studying brain metabolism and measuring important metabolites. This initiative underscores the importance of maintaining a domestic supply of these chemicals to support ongoing research efforts at NIH and NIMH. Interested parties must submit their responses, including company information and capability statements, electronically to Joseph Kennedy at joseph.kennedy@nih.gov by January 22, 2025, as the anticipated contract duration is 12 months.
    In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking innovative proposals for the development of In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems. The initiative aims to address the challenges posed by light scattering in biological tissues, which currently limits the effectiveness of non-invasive optical imaging techniques in assessing tissue function and structure. This funding opportunity encourages the advancement of next-generation imaging technologies that can achieve deeper penetration and higher resolution in biological systems. Interested applicants should note that the application due date is March 7, 2025, by 5:00 PM local time, and are encouraged to submit a letter of intent by the same date. For further inquiries, contact Jonathan Pollock at jpollock@mail.nih.gov or Robert Bailey at rob.bailey@nih.gov.
    Assay Kits for Lumipulse instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of assay kits for the Lumipulse instrument, aimed at quantifying specific biomarkers related to Alzheimer's Disease. The acquisition includes a total of 4,410 assays for measuring abeta42, abeta40, and pTau 217, which will support ongoing research into cognitive decline and neurodegeneration using samples from the Baltimore Longitudinal Study of Aging. Interested vendors must submit their quotations by 5:00 p.m. Eastern Time on January 15, 2025, and can direct inquiries to Iris Merscher at iris.merscher@nih.gov or by phone at 301-827-2547. This procurement is conducted under simplified acquisition procedures and is open to all qualified offerors without set-aside restrictions.
    SOURCES SOUGHT: Automated Cell Dissociation Apparatus
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide an automated cell dissociation apparatus for the National Institute on Aging's Laboratory of Neurogenetics. The primary objective of this procurement is to acquire equipment capable of isolating single nuclei from human and mouse brain tissues, which is crucial for advancing research on neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease. The preferred model for this apparatus is the S2 Genomics Singulator 100 Cell Dissociation Platform, which must meet specific requirements including bench-top compatibility, single-use cartridges, and customizable software for protocol adjustments. Interested companies must submit their capability statements by January 17, 2025, to Rashiid Cummins at rashiid.cummins@nih.gov, ensuring they include all necessary documentation and adhere to the specified format.
    Development of Radiation/Nuclear Medical Countermeasures (MCMs) And Biodosimetry Devices
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the development of Radiation/Nuclear Medical Countermeasures (MCMs) and biodosimetry devices. The primary objectives are to create MCMs that mitigate normal tissue injuries from ionizing radiation and to advance biodosimetry methods to enhance triage and treatment during radiation emergencies, with each proposal focusing on one of these goals. This initiative is crucial for national preparedness against potential radiological incidents, as it aims to improve the response to radiation exposure and associated health risks. Proposals are due by March 19, 2025, and interested parties must register in the System for Award Management (SAM); the estimated cost and fixed fee for the contract are to be determined. For further inquiries, contact Albert Nguyen at nguyenal@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov.
    A--National Gene Vector Biorepository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the National Gene Vector Biorepository (NGVB) contract, aimed at supporting gene therapy research for the National Heart, Lung, and Blood Institute (NHLBI). The contract will involve archiving biological specimens, conducting DNA and RNA extractions, and developing assays, while ensuring compliance with FDA regulations and Good Laboratory Practices (GLP). This initiative is critical for advancing gene therapy capabilities and enhancing research resources, with an expected proposal submission deadline of January 10, 2025, and a revised due date for proposals set at 2:00 PM EST on January 15, 2025. Interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or +1 301 496 2153 for further information.